RESUMEN

Within the larger ABC superfamily of ATPases, ABCF family members eEF3 in Saccharomyces cerevisiae and EttA in Escherichia coli have been found to function as ribosomal translation factors. Several other ABCFs including biochemically characterized VgaA, LsaA and MsrE confer resistance to antibiotics that target the peptidyl transferase center and exit tunnel of the ribosome. However, the diversity of ABCF subfamilies, the relationships among subfamilies and the evolution of antibiotic resistance (ARE) factors from other ABCFs have not been explored. To address this, we analyzed the presence of ABCFs and their domain architectures in 4505 genomes across the tree of life. We find 45 distinct subfamilies of ABCFs that are widespread across bacterial and eukaryotic phyla, suggesting that they were present in the last common ancestor of both. Surprisingly, currently known ARE ABCFs are not confined to a distinct lineage of the ABCF family tree, suggesting that ARE can readily evolve from other ABCF functions. Our data suggest that there are a number of previously unidentified ARE ABCFs in antibiotic producers and important human pathogens. We also find that ATPase-deficient mutants of all four E. coli ABCFs (EttA, YbiT, YheS and Uup) inhibit protein synthesis, indicative of their ribosomal function, and demonstrate a genetic interaction of ABCFs Uup and YheS with translational GTPase BipA involved in assembly of the 50S ribosome subunit. Finally, we show that the ribosome-binding resistance factor VmlR from Bacillus subtilis is localized to the cytoplasm, ruling out a role in antibiotic efflux.

Asunto(s)

Transportadoras de Casetes de Unión a ATP/química , Transportadoras de Casetes de Unión a ATP/metabolismo , Adenosina Trifosfatasas/metabolismo , Farmacorresistencia Microbiana/genética , Biosíntesis de Proteínas/efectos de los fármacos , Ribosomas/metabolismo , Transportadoras de Casetes de Unión a ATP/clasificación , Transportadoras de Casetes de Unión a ATP/genética , Adenosina Trifosfatasas/genética , Antibacterianos/farmacología , Bacillus subtilis/metabolismo , Farmacorresistencia Bacteriana/efectos de los fármacos , Farmacorresistencia Bacteriana/genética , Escherichia coli/metabolismo , Proteínas de Escherichia coli/genética , GTP Fosfohidrolasas/metabolismo , Humanos , Modelos Moleculares , Peptidil Transferasas/efectos de los fármacos , Conformación Proteica , Dominios Proteicos , Ribosomas/química , Ribosomas/efectos de los fármacos , Ribosomas/genética , Saccharomyces cerevisiae/metabolismo

RESUMEN

The bacterial cell wall peptidoglycan contains unusual l- and d-amino acids assembled as branched peptides. Insight into the biosynthesis of the polymer has been hampered by limited access to substrates and to suitable polymerization assays. Here we report the full synthesis of the peptide stem of peptidoglycan precursors from two pathogenic bacteria, Enterococcus faecium and Mycobacterium tuberculosis, and the development of a sensitive post-derivatization assay for their cross-linking by l,d-transpeptidases. Access to series of stem peptides showed that amidation of free carboxyl groups is essential for optimal enzyme activity, in particular the amidation of diaminopimelate (DAP) residues for the cross-linking activity of the l,d-transpeptidase LdtMt2 from M. tuberculosis. Accordingly, construction of a conditional mutant established the essential role of AsnB indicating that this DAP amidotransferase is an attractive target for the development of anti-mycobacterial drugs.

Asunto(s)

Enterococcus faecium/enzimología , Mycobacterium tuberculosis/enzimología , Peptidoglicano/biosíntesis , Peptidil Transferasas/metabolismo , Transaminasas/metabolismo , Pared Celular/metabolismo , Enterococcus faecium/química , Enterococcus faecium/genética , Mycobacterium tuberculosis/química , Mycobacterium tuberculosis/genética , Peptidil Transferasas/efectos de los fármacos , beta-Lactamas/química

RESUMEN

Hygromycin A (HygA) binds to the large ribosomal subunit and inhibits its peptidyl transferase (PT) activity. The presented structural and biochemical data indicate that HygA does not interfere with the initial binding of aminoacyl-tRNA to the A site, but prevents its subsequent adjustment such that it fails to act as a substrate in the PT reaction. Structurally we demonstrate that HygA binds within the peptidyl transferase center (PTC) and induces a unique conformation. Specifically in its ribosomal binding site HygA would overlap and clash with aminoacyl-A76 ribose moiety and, therefore, its primary mode of action involves sterically restricting access of the incoming aminoacyl-tRNA to the PTC.

Asunto(s)

Cinamatos/química , Cinamatos/farmacología , Higromicina B/análogos & derivados , Inhibidores de la Síntesis de la Proteína/química , Inhibidores de la Síntesis de la Proteína/farmacología , Subunidades Ribosómicas Grandes Bacterianas/química , Subunidades Ribosómicas Grandes Bacterianas/efectos de los fármacos , Sitios de Unión , Cinamatos/metabolismo , Cristalografía por Rayos X , Higromicina B/química , Higromicina B/metabolismo , Higromicina B/farmacología , Modelos Moleculares , Peptidil Transferasas/química , Peptidil Transferasas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/metabolismo , Aminoacil-ARN de Transferencia/metabolismo , Subunidades Ribosómicas Grandes Bacterianas/enzimología , Subunidades Ribosómicas Grandes Bacterianas/metabolismo

RESUMEN

In the absence of elongation factor EF-G, ribosomes undergo spontaneous, thermally driven fluctuation between the pre-translocation (classical) and intermediate (hybrid) states of translocation. These fluctuations do not result in productive mRNA translocation. Extending previous findings that the antibiotic sparsomycin induces translocation, we identify additional peptidyl transferase inhibitors that trigger productive mRNA translocation. We find that antibiotics that bind the peptidyl transferase A site induce mRNA translocation, whereas those that do not occupy the A site fail to induce translocation. Using single-molecule FRET, we show that translocation-inducing antibiotics do not accelerate intersubunit rotation, but act solely by converting the intrinsic, thermally driven dynamics of the ribosome into translocation. Our results support the idea that the ribosome is a Brownian ratchet machine, whose intrinsic dynamics can be rectified into unidirectional translocation by ligand binding.

Asunto(s)

Antibacterianos/farmacología , Escherichia coli/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , Transporte de ARN/efectos de los fármacos , ARN Mensajero/efectos de los fármacos , Subunidades Ribosómicas Grandes Bacterianas/efectos de los fármacos , Antibacterianos/metabolismo , Cloranfenicol/metabolismo , Cloranfenicol/farmacología , Clindamicina/metabolismo , Clindamicina/farmacología , Inhibidores Enzimáticos/metabolismo , Inhibidores Enzimáticos/farmacología , Escherichia coli/genética , Escherichia coli/metabolismo , Proteínas de Escherichia coli/efectos de los fármacos , Proteínas de Escherichia coli/metabolismo , Transferencia Resonante de Energía de Fluorescencia , Lincomicina/metabolismo , Lincomicina/farmacología , Factor G de Elongación Peptídica/efectos de los fármacos , Factor G de Elongación Peptídica/metabolismo , Peptidil Transferasas/efectos de los fármacos , Peptidil Transferasas/metabolismo , ARN Bacteriano/efectos de los fármacos , ARN Bacteriano/metabolismo , ARN Mensajero/metabolismo , ARN de Transferencia/efectos de los fármacos , ARN de Transferencia/metabolismo , Subunidades Ribosómicas Grandes Bacterianas/metabolismo , Esparsomicina/metabolismo , Esparsomicina/farmacología

RESUMEN

The oxazolidinones are one of the newest classes of antibiotics. They inhibit bacterial growth by interfering with protein synthesis. The mechanism of oxazolidinone action and the precise location of the drug binding site in the ribosome are unknown. We used a panel of photoreactive derivatives to identify the site of action of oxazolidinones in the ribosomes of bacterial and human cells. The in vivo crosslinking data were used to model the position of the oxazolidinone molecule within its binding site in the peptidyl transferase center (PTC). Oxazolidinones interact with the A site of the bacterial ribosome where they should interfere with the placement of the aminoacyl-tRNA. In human cells, oxazolidinones were crosslinked to rRNA in the PTC of mitochondrial, but not cytoplasmic, ribosomes. Interaction of oxazolidinones with the mitochondrial ribosomes provides a structural basis for the inhibition of mitochondrial protein synthesis, which is linked to clinical side effects associated with oxazolidinone therapy.

Asunto(s)

Mitocondrias/efectos de los fármacos , Oxazolidinonas/farmacología , Peptidil Transferasas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/farmacología , ARN Ribosómico/efectos de los fármacos , Programas Informáticos , Acetamidas , Antiinfecciosos/química , Antiinfecciosos/farmacología , Sitios de Unión/efectos de los fármacos , Reactivos de Enlaces Cruzados/química , Reactivos de Enlaces Cruzados/farmacología , Citoplasma/efectos de los fármacos , Citoplasma/enzimología , Resistencia a Medicamentos/genética , Escherichia coli/efectos de los fármacos , Escherichia coli/enzimología , Humanos , Linezolid , Mitocondrias/enzimología , Modelos Moleculares , Estructura Molecular , Mutación/genética , Oxazolidinonas/química , Peptidil Transferasas/metabolismo , Inhibidores de la Síntesis de la Proteína/química , ARN Bacteriano/genética , ARN Bacteriano/metabolismo , ARN Ribosómico/metabolismo , ARN Ribosómico 23S , Aminoacil-ARN de Transferencia/antagonistas & inhibidores , Aminoacil-ARN de Transferencia/metabolismo , Coloración y Etiquetado , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/enzimología

RESUMEN

The mitochondrial rRNA of the tapeworm species Echinococcus multilocularis carries an adenine at sequence position 2058 (numbering according to that for Escherichia coli) of the large-subunit rRNA (lsrRNA), while the nucleus-encoded rRNA, as determined in this study, is characterized by 2058G. This indicates a dichotomy in the drug susceptibilities of ribosomes: cytoplasmic ribosomes are predicted to be resistant to macrolide antibiotics, while mitochondrial ribosomes lack the most common chromosomal resistance determinant, lsrRNA 2058G. Upon incubation with the macrolide clarithromycin, the formation of vesicles from metacestode tissue was reduced in a dose-dependent manner. Electron microscopy revealed distinct morphological alterations both of the mitochondria and of the vesicle wall (e.g., loss of microtriches) in drug-treated vesicles. Adult worms lost their motility and displayed morphological changes (shortening and constriction of proglottids and the presence of vacuoles) upon incubation with clarithromycin. Our findings demonstrate that macrolides have distinct in vitro effects on E. multilocularis, endorsing the use of sequence-based in silico approaches for exploitation of available ribosomal drugs as anthelmintic agents.

Asunto(s)

Antibacterianos/farmacología , Claritromicina/farmacología , Echinococcus multilocularis/efectos de los fármacos , Ribosomas/efectos de los fármacos , Animales , Echinococcus multilocularis/genética , Echinococcus multilocularis/crecimiento & desarrollo , Macrólidos/farmacología , Microscopía Electrónica , Mitocondrias/efectos de los fármacos , Mitocondrias/ultraestructura , Datos de Secuencia Molecular , Pruebas de Sensibilidad Parasitaria , Peptidil Transferasas/efectos de los fármacos , Peptidil Transferasas/genética , ARN Ribosómico/genética , Análisis de Secuencia de ADN

RESUMEN

The widespread use of antibiotics has encouraged the development of drug resistance in pathogenic bacteria. In order to overcome this problem, the modification of existing antibiotics and/or the identification of targets for the design of new antibiotics is currently being undertaken. Bifunctional penicillin-binding proteins (PBPs) are membrane-associated molecules whose transpeptidase (TP) activity is irreversibly inhibited by beta-lactam antibiotics and whose glycosyltransferase (GT) activity represents a potential target in the antibacterial fight. In this work, we describe the expression and the biochemical characterization of the soluble extracellular region of Streptococcus pneumoniae PBP1b (PBP1b*). The acylation efficiency for benzylpenicillin and cefotaxime was characterized by stopped-flow fluorometry and a 40-kDa stable TP domain was generated after limited proteolysis. In order to analyze the GT activity of PBP1b*, we developed an electrophoretic assay which monitors the fluorescence signal from PBP1b*-bound dansylated lipid II. This binding was inhibited by the antibiotic moenomycin and was specific for the GT domain, since no signal was observed in the presence of the purified functional TP domain. Binding studies performed with truncated forms of PBP1b* demonstrated that the first conserved motif of the GT domain is not required for the recognition of lipid II, whereas the second motif is necessary for such interaction.

Asunto(s)

Proteínas Bacterianas , Proteínas Portadoras , Hexosiltransferasas/metabolismo , Complejos Multienzimáticos/metabolismo , Muramoilpentapéptido Carboxipeptidasa , Peptidil Transferasas/metabolismo , Streptococcus pneumoniae/química , Uridina Difosfato Ácido N-Acetilmurámico/análogos & derivados , Secuencia de Aminoácidos , Antibacterianos/metabolismo , Antibacterianos/farmacología , Secuencia de Bases , Cefotaxima/metabolismo , Electroforesis/métodos , Fluorescencia , Fluorometría/métodos , Hexosiltransferasas/efectos de los fármacos , Hexosiltransferasas/genética , Cinética , Datos de Secuencia Molecular , Complejos Multienzimáticos/efectos de los fármacos , Complejos Multienzimáticos/genética , Oligosacáridos/metabolismo , Oligosacáridos/farmacología , Penicilina G/metabolismo , Proteínas de Unión a las Penicilinas , Peptidil Transferasas/efectos de los fármacos , Peptidil Transferasas/genética , Estructura Terciaria de Proteína , Tripsina/metabolismo , Uridina Difosfato Ácido N-Acetilmurámico/metabolismo

RESUMEN

Neisseria gonorrhoeae strains with reduced susceptibility to cefixime (MICs, 0.25 to 0.5 micro g/ml) were isolated from male urethritis patients in Tokyo, Japan, in 2000 and 2001. The resistance to cephems including cefixime and penicillin was transferred to a susceptible recipient, N. gonorrhoeae ATCC 19424, by transformation of the penicillin-binding protein 2 gene (penA) that had been amplified by PCR from a strain with reduced susceptibility to cefixime (MIC, 0.5 micro g/ml). The sequences of penA in the strains with reduced susceptibilities to cefixime were different from those of other susceptible isolates and did not correspond to the reported N. gonorrhoeae penA gene sequences. Some regions in the transpeptidase-encoding domain in this penA gene were similar to those in the penA genes of Neisseria perflava (N. sicca), Neisseria cinerea, Neisseria flavescens, and Neisseria meningitidis. These results showed that a mosaic-like structure in the penA gene conferred reductions in the levels of susceptibility of N. gonorrhoeae to cephems and penicillin in a manner similar to that found for N. meningitidis and Streptococcus pneumoniae.

Asunto(s)

Proteínas Bacterianas , Proteínas Portadoras , Cefixima/farmacología , Hexosiltransferasas/genética , Complejos Multienzimáticos/genética , Muramoilpentapéptido Carboxipeptidasa , Neisseria gonorrhoeae/genética , Peptidil Transferasas/genética , Secuencia de Aminoácidos , Hexosiltransferasas/efectos de los fármacos , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Mosaicismo/genética , Complejos Multienzimáticos/efectos de los fármacos , Neisseria gonorrhoeae/efectos de los fármacos , Neisseria gonorrhoeae/aislamiento & purificación , Proteínas de Unión a las Penicilinas , Peptidil Transferasas/efectos de los fármacos

RESUMEN

Functional Escherichia coli 50S ribosomal subunits can be reconstituted from their natural rRNA and protein components. However, when the assembly is performed with in vitro-transcribed 23S rRNA, the reconstitution efficiency is diminished by four orders of magnitude. We tested a variety of chemical chaperones (compounds that are typically used for protein folding), putative RNA chaperones (proteins) and ribosome-targeted antibiotics (small-molecule ligands) that might be reasoned to aid in folding and assembly. Addition of the osmolyte trimethylamine-oxide (TMAO) and the ketolide antibiotic telithromycin (HMR3647) to the reconstitution stimulates its efficiency up to 100-fold yielding a substantially improved system for the in vitro analysis of mutant ribosomes.

Asunto(s)

Escherichia coli/genética , Cetólidos , Macrólidos , Metilaminas/farmacología , ARN Ribosómico 23S , Ribosomas/genética , Antibacterianos/farmacología , Secuencia de Bases , Carbohidratos/farmacología , Caseínas/farmacología , Lípidos/farmacología , Magnesio/metabolismo , Datos de Secuencia Molecular , Mutación , Peptidil Transferasas/efectos de los fármacos , Peptidil Transferasas/genética , Peptidil Transferasas/metabolismo , Proteínas de Vegetales Comestibles/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , ARN de Transferencia/genética , ARN de Transferencia/metabolismo , Ribosomas/efectos de los fármacos , Ribosomas/metabolismo , Transcripción Genética

RESUMEN

The affinity of [(3)H]benzylpenicillin for penicillin-binding protein (PBP) 3A was reduced in 25 clinical isolates of beta-lactamase-negative ampicillin (AMP)-resistant (BLNAR) Haemophilus influenzae for which the AMP MIC was > or =1.0 microg/ml. The affinities of PBP 3B and PBP 4 were also reduced in some strains. The sequences of the ftsI gene encoding the transpeptidase domain of PBP 3A and/or PBP 3B and of the dacB gene encoding PBP 4 were determined for these strains and compared to those of AMP-susceptible Rd strains. The BLNAR strains were classified into three groups on the basis of deduced amino acid substitutions in the ftsI gene, which is thought to be involved in septal peptidoglycan synthesis. His-517, near the conserved Lys-Thr-Gly (KTG) motif, was substituted for Arg-517 in group I strains (n = 9), and Lys-526 was substituted for Asn-526 in group II strains (n = 12). In group III strains (n = 4), three residues (Met-377, Ser-385, and Leu-389), positioned near the conserved Ser-Ser-Asn (SSN) motif, were replaced with Ile, Thr, and Phe, respectively, in addition to the replacement with Lys-526. The MICs of cephem antibiotics with relatively high affinities for PBP 3A and PBP 3B were higher than those of AMP and meropenem for group III strains. The MICs of beta-lactams for H. influenzae transformants into which the ftsI gene from BLNAR strains was introduced were as high as those for the donors, and PBP 3A and PBP 3B showed decreased affinities for beta-lactams. There was no clear relationship between 7-bp deletions in the dacB gene and AMP susceptibility. Even though mutations in another gene(s) may be involved in beta-lactam resistance, these data indicate that mutations in the ftsI gene are the most important for development of resistance to beta-lactams in BLNAR strains.

Asunto(s)

Ampicilina/farmacología , Antibacterianos/farmacología , Proteínas Bacterianas , Proteínas Portadoras , Haemophilus influenzae/efectos de los fármacos , Hexosiltransferasas/efectos de los fármacos , Complejos Multienzimáticos/efectos de los fármacos , Muramoilpentapéptido Carboxipeptidasa , Resistencia a las Penicilinas/genética , Peptidil Transferasas/efectos de los fármacos , beta-Lactamasas/biosíntesis , Haemophilus influenzae/clasificación , Haemophilus influenzae/metabolismo , Hexosiltransferasas/genética , Pruebas de Sensibilidad Microbiana , Complejos Multienzimáticos/genética , Proteínas de Unión a las Penicilinas , Peptidil Transferasas/genética , Serotipificación , Relación Estructura-Actividad

RESUMEN

Various ethyl and benzyl spermine analogues, including the anticancer agent N1,N12-bis(ethyl)spermine, were studied for their ability to affect the growth of cultured Escherichia coli cells, to inhibit [3H]putrescine and [3H]spermine uptake into cells, and to modulate the peptidyltransferase activity (EC 2. 3. 2. 12). Relative to other cell lines, growth of E. coli was uniquely insensitive to these analogues. Nevertheless, these analogues conferred similar modulation of in vitro protein synthesis and inhibition of [3H]putrescine and [3H]spermine uptake, as is seen in other cell types. Thus, both ethyl and benzyl analogues of spermine not only promote the formation and stabilization of the initiator ribosomal ternary complex, but they also have a sparing effect on the Mg2+ requirements. Also, in a complete cell-free protein-synthesizing system, these analogues at low concentrations stimulated peptide bond formation, whereas at higher concentrations, they inhibited the reaction. The ranking order for stimulation of peptide-bond formation by the analogues was N4,N9-dibenzylspermine > N4, N9-bis(ethyl)spermine congruent with N1-ethylspermine > N1, N12-bis(ethyl)spermine, whereas the order of analogue potency regarding the inhibitory effect was inverted, with inhibition constant values of 10, 3.1, 1.5, and 0.98 microM, respectively. Although the above analogues failed to interact with the putrescine-specific uptake system, they exhibited high affinity for the polyamine uptake system encoded by the potABCD operon. Despite this fact, none of the analogues could be internalized by the polyamine transport system, and therefore they could not influence the intracellular polyamine pools and growth of E. coli cells.

Asunto(s)

Escherichia coli/efectos de los fármacos , Extensión de la Cadena Peptídica de Translación/efectos de los fármacos , Peptidil Transferasas/efectos de los fármacos , Poliaminas/metabolismo , Espermina/análogos & derivados , Compuestos de Bencilo/química , Transporte Biológico/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Escherichia coli/crecimiento & desarrollo , Etano/análogos & derivados , Modelos Químicos , Ribosomas/efectos de los fármacos

RESUMEN

This reports the synthesis and in vitro antimicrobial properties of a series of 2-thioether-linked quinolonyl-carbapenems. Although the title compounds exhibited broad spectrum activity, the MICs were generally higher than those observed for selected benchmark carbapenems, quinolonyl-penems, and quinolones. Enzyme assays suggested that the title compounds are potent inhibitors of penicillin binding proteins and inefficient inhibitors of bacterial DNA-gyrase. Uptake studies indicated that the new compounds are not substrates for the norA encoded quinolone efflux pump.

Asunto(s)

Carbapenémicos/química , Carbapenémicos/farmacología , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Quinolonas/química , Proteínas Bacterianas/efectos de los fármacos , Carbapenémicos/síntesis química , Proteínas Portadoras/efectos de los fármacos , División Celular , Bacterias Gramnegativas/enzimología , Bacterias Grampositivas/enzimología , Hexosiltransferasas/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Proteínas Asociadas a Resistencia a Múltiples Medicamentos , Complejos Multienzimáticos/efectos de los fármacos , Muramoilpentapéptido Carboxipeptidasa/efectos de los fármacos , Proteínas de Unión a las Penicilinas , Peptidil Transferasas/efectos de los fármacos , Relación Estructura-Actividad , Inhibidores de Topoisomerasa II

RESUMEN

The effect of NH4+ and K+ ions on the activity of ribosomal peptidyltransferase was investigated in a model system derived from Escherichia coli, in which AcPhe-puromycin is produced by a pseudo-first-order reaction between the preformed AcPhe-tRNA-poly(U)-ribosome complex (complex C) and excess puromycin. Detailed kinetic analysis suggests that both NH4+ and K+ ions act as essential activators of peptidyltransferase by filling randomly, but not cooperatively, multiple sites on the ribosome. With respect to the NH4+ effect at 25 degrees C. the values of the molecular interaction coefficient (n), the dissociation constant (KA), and the apparent catalytic rate constant (kmax) of peptidyltransferase at saturating levels of NH4+ and puromycin are 1.99, 268.7 mM and 24.8 min(-1), respectively. The stimulation of peptidyltransferase by K+ ions at 25 degrees C (n = 4.38, KA = 95.5 mM, kmax = 9.6 min[-1]) is not as marked as that caused by NH4+ ions. Furthermore, it is evident that NH4+ at high concentration (200 mM) is effective in filling regulatory sites of complex C, which are responsible for the modulatory effect of spermine. The combination of NH4+ ions (200 mM) with spermine (300 microM) produces an additive increase in peptidyltransferase activity. Taken together, these findings suggest the involvement of two related pathways in the regulation of peptidyltransferase activity, one mediated by specific monovalent cations and the other mediated by spermine.

Asunto(s)

Péptidos/metabolismo , Peptidil Transferasas/metabolismo , Potasio/metabolismo , Compuestos de Amonio Cuaternario/metabolismo , Ribosomas/enzimología , Espermina/metabolismo , Catálisis , Cationes Monovalentes , Relación Dosis-Respuesta a Droga , Activación Enzimática/efectos de los fármacos , Cinética , Peptidil Transferasas/efectos de los fármacos , Potasio/farmacología , Puromicina/biosíntesis , Compuestos de Amonio Cuaternario/farmacología , Aminoacil-ARN de Transferencia/efectos de los fármacos , Aminoacil-ARN de Transferencia/metabolismo , Espermina/farmacología

RESUMEN

In an effort to elucidate the role of potassium ions in the formation of peptide bond, we have used the reaction between puromycin and a ribosomal complex (from rabbit reticulocytes) bearing the donor substrate, AcPhe-tRNA, prebound at the so-called P site (puromycin-reactive state). This reaction can be analyzed as a first-order reaction. At saturating concentrations of puromycin (S) the first-order rate constant (k(max)S) is a measure of the apparent catalytic rate constant of peptidyltransferase in the puromycin reaction. This k(max)S depends on the concentration of potassium ions and increases when the concentration of K+ is increased. The data suggest a kinetic model in which potassium acts as an essential activator in the puromycin reaction. A single molecule of potassium participates in the mechanism of activation. The kinetics correspond to a sequential addition of potassium and puromycin to two separate and independent sites on the ribosome. At saturating levels of both K+ and S the maximal value for the catalytic rate constant of peptidyltransferase (k(p)) is equal to 20 min(-1) at 25 degrees C.

Asunto(s)

Biosíntesis de Péptidos , Peptidil Transferasas/efectos de los fármacos , Potasio/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , Animales , Cationes Monovalentes/farmacología , Sistema Libre de Células , Relación Dosis-Respuesta a Droga , Células Eucariotas/metabolismo , Cinética , Modelos Químicos , Puromicina/metabolismo , Conejos , Reticulocitos/metabolismo

RESUMEN

By using a broad-host-range vector, pUCP27, the Pseudomonas aeruginosa and Escherichia coli pbpB genes, which encode penicillin-binding protein 3 (PBP3), were separately overexpressed in a P. aeruginosa strain, PAO4089, that is deficient in producing chromosomal beta-lactamase. Susceptibility studies indicated that overproduction of the P. aeruginosa PBP3 in PAO4089 resulted in twofold-increased resistance to aztreonam, fourfold-increased resistance to cefepime and cefsulodin, and eightfold-increased resistance to ceftazidime, whereas overproduction of the P. aeruginosa PBP3 in PAO4089 did not affect susceptibility to PBP1-targeted cephaloridine or PBP2-targeted imipenem. Similar results were obtained with PAO4089 overproducing E. coli PBP3, with the exception that there was no influence on the MICs or minimal bactericidal concentrations of cefsulodin and cefepime, which have very low affinities for E. coli PBP3. These data are consistent with the conclusion that PBP3 has to achieve a certain level of saturation, with beta-lactams targeted to this protein, to result in cell inhibition or death.

Asunto(s)

Antibacterianos/farmacología , Proteínas Bacterianas , Proteínas Portadoras , Cefalosporinas/farmacología , Proteínas de Escherichia coli , Hexosiltransferasas/biosíntesis , Complejos Multienzimáticos/biosíntesis , Muramoilpentapéptido Carboxipeptidasa , Peptidoglicano Glicosiltransferasa , Peptidil Transferasas/biosíntesis , Pseudomonas aeruginosa/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Escherichia coli/metabolismo , Hexosiltransferasas/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Complejos Multienzimáticos/efectos de los fármacos , Proteínas de Unión a las Penicilinas , Peptidil Transferasas/efectos de los fármacos , Pseudomonas aeruginosa/metabolismo

RESUMEN

Induction of Phase II enzymes of the [Ah] gene battery by L-buthionine (S,R)-sulfoximine (BSO) and other agents was examined in mouse hepatoma Hepa-1c1c7 cells. BSO, a nonelectrophilic inhibitor of gamma-glutamylcysteine synthetase (GCS), is routinely used to examine the toxicological implications of GSH depletion. Exposure to BSO for 24 h produced a 75-85% depletion of GSH levels, proportional to the inhibition of GCS activity, as well as small increases in the UDP-glucuronosyltransferase (UGT, 60%) and glutathione transferase (GST, 30%) enzyme activities in Hepa-1 wild-type (wt) cells. However, for the NAD(P)H:menadione oxidoreductase (NMO1) and cytosolic aldehyde dehydrogenase class 3 (AHD4) enzyme activities, BSO produced larger increases (110% and 170%, respectively). The mechanisms of NMO1 and AHD4 induction were examined further. In Hepa-1 wt cells, NMO1 and AHD4 activities were increased by the aromatic hydrocarbon inducer 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and by the electrophile tert-butylhydroquinone (tBHQ), known inducing agents for these enzymes. However, NMO1 and AHD4 were induced in Ah receptor nuclear translocation-defective mutant (c4) cells by BSO and tBHQ, but not by TCDD, suggesting that the induction by BSO and tBHQ is not Ah receptor-mediated. In wt cells, N-acetylcysteine produced a concentration-dependent increase in intracellular cysteine levels, but not GSH levels, in the absence or presence of BSO. Furthermore, N-acetylcysteine had no effect on NMO1 activity under any conditions examined, suggesting that GSH levels per se, rather than change in overall thiol status, might be mediating increased NMO1 activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Asunto(s)

Aminoaciltransferasas , Antimetabolitos/farmacología , Metionina Sulfoximina/análogos & derivados , Peptidil Transferasas/biosíntesis , Animales , Antioxidantes/farmacología , Northern Blotting , Butionina Sulfoximina , Línea Celular , Dactinomicina/farmacología , Inducción Enzimática/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Hidroquinonas/farmacología , Neoplasias Hepáticas Experimentales , Metionina Sulfoximina/farmacología , Ratones , Peptidil Transferasas/efectos de los fármacos , Compuestos de Sulfhidrilo/metabolismo

RESUMEN

The site of ribosome stalling in the leader of cat transcripts is critical to induction of downstream translation. Site-specific stalling requires translation of the first five leader codons and the presence of chloramphenicol, a sequence-independent inhibitor of ribosome elongation. We demonstrate in this report that a synthetic peptide (the 5-mer) corresponding to the N-terminal five codons of the cat-86 leader inhibits peptidyl transferase in vitro. The N-terminal 2-, 3-, and 4-mers and the reverse 5-mer (reverse amino acid sequence of the 5-mer) are virtually without effect on peptidyl transferase. A missense mutation in the cat-86 leader that abolishes induction in vivo corresponds to an amino acid replacement in the 5-mer that completely relieves peptidyl transferase inhibition. In contrast, a missense mutation that does not interfere with in vivo induction corresponds to an amino acid replacement in the 5-mer that does not significantly alter peptidyl transferase inhibition. Our results suggest that peptidyl transferase inhibition by the nascent cat-86 5-mer peptide may be the primary determinant of the site of ribosome stalling in the leader. A model based on this concept can explain the site specificity of ribosome stalling as well as the response of induction to very low levels of the antibiotic inducer.

Asunto(s)

Cloranfenicol O-Acetiltransferasa/metabolismo , Peptidil Transferasas/antagonistas & inhibidores , Señales de Clasificación de Proteína/metabolismo , Secuencia de Aminoácidos , Bacillus subtilis/enzimología , Bacillus subtilis/genética , Secuencia de Bases , Cloranfenicol/farmacología , Cloranfenicol O-Acetiltransferasa/genética , Farmacorresistencia Microbiana/genética , Inducción Enzimática , Eritromicina/farmacología , Cinética , Lincomicina/farmacología , Datos de Secuencia Molecular , Peptidil Transferasas/efectos de los fármacos , Señales de Clasificación de Proteína/genética , ARN Bacteriano , Ribosomas/metabolismo

RESUMEN

The antibiotic erythromycin inhibits protein synthesis by binding to the 50 S ribosomal subunit, where the drug interacts with the unpaired bases 2058A and 2059A in the peptidyl transferase loop of 23 S rRNA. We used a chemical modification approach to analyse conformational changes that are induced by mutations in the peptidyl transferase loop, and to determine how these changes affect drug interaction. Mutations at positions 2057 (G-->A) and 2058 (A-->G, or -->U), all of which confer drug resistance, induce a more open conformation in the peptidyl transferase loop. Erythromycin still protects against chemical modification in the mutant peptidyl transferase loops, but the affinity of the drug interaction is reduced 20-fold in the 2057A mutant, 10(3)-fold in the 2058U mutant and 10(4)-fold in the 2058G mutant. Single mutations at position 2032 in the adjacent hairpin loop, which have previously been shown to alter drug tolerances, gave no detectable effects on the structure of the peptidyl transferase loop or on erythromycin binding. Dual mutations at positions 2032 and 2058, however, induce a marked change in the rRNA conformation with opening of the phylogenetically conserved base-pair 2063C.2447G, and confer a slow growth, drug-sensitive phenotype. The data suggest that the target site of erythromycin lies within the peptidyl transferase loop, and that limited disruption of the conformation of this site reduces drug binding, and consequently confers resistance. In addition, there is structurally and functionally important interaction between the drug target site in the peptidyl transferase loop and position 2032.

Asunto(s)

Eritromicina/farmacología , Escherichia coli/efectos de los fármacos , Peptidil Transferasas/efectos de los fármacos , ARN Ribosómico 23S/efectos de los fármacos , Ribosomas/metabolismo , Secuencia de Bases , Sitios de Unión , Farmacorresistencia Microbiana/genética , Eritromicina/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Datos de Secuencia Molecular , Mutación/fisiología , Peptidil Transferasas/genética , Peptidil Transferasas/metabolismo , Fenotipo , Conformación Proteica , ARN Bacteriano/efectos de los fármacos , ARN Bacteriano/genética , ARN Bacteriano/metabolismo , ARN Ribosómico 23S/genética , ARN Ribosómico 23S/metabolismo

RESUMEN

The effects of fosfomycin on penicillin-binding proteins (PBPs) were studied on the methicillin-resistant Staphylococcus aureus strain CIP (Collection de l'Institut Pasteur, Paris, France) 65-25 and on a methicillin-susceptible S. aureus strain CIP 65-6. The combinations of fosfomycin and oxacillin were synergistic, additive or antagonistic, depending on antibiotic concentrations. Fosfomycin induced modifications of the PBP profile of the two strains studied. In particular, it increased the expression of PBP2. This suggested that this protein is inducible; the only PBP not affected by fosfomycin was PBP3.

Asunto(s)

Proteínas Bacterianas , Proteínas Portadoras , Fosfomicina/farmacología , Hexosiltransferasas/efectos de los fármacos , Complejos Multienzimáticos/efectos de los fármacos , Muramoilpentapéptido Carboxipeptidasa , Oxacilina/farmacología , Peptidil Transferasas/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Sinergismo Farmacológico , Quimioterapia Combinada/farmacología , Hexosiltransferasas/química , Resistencia a la Meticilina , Complejos Multienzimáticos/química , Proteínas de Unión a las Penicilinas , Peptidil Transferasas/química